Exploring the Darobactin Class of Antibiotics: A Comprehensive Review from Discovery to Recent Advancements
ACS Infectious Diseases · 2024
DOI: 10.1021/acsinfecdis.4c00412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Akash Dutta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Bombay, Mumbai 400076, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Wadhwani Research Centre for Bioengineering, Indian Institute of Technology Bombay, University Grants Commission, Science and Engineering Research Board.
Abstract (Originalsprache)
The prevalence of antimicrobial resistance in Gram-negative bacteria poses a greater challenge due to their intrinsic resistance to many antibiotics. Recently, darobactins have emerged as a novel class of antibiotics originating from previously unexplored Gram-negative bacterial species such as Photorhabdus, Vibrio, Pseudoalteromonas and Yersinia. Darobactins belong to the ribosomally synthesized and post-translationally modified peptide (RiPP) class of antibiotics, exhibiting selective activity against Gram-negative bacteria. They target the β-barrel assembly machinery (BAM), which is crucial for the maturation and insertion of outer membrane proteins in Gram-negative bacteria. The dar operon in the producer's genome encodes for the synthesis of darobactins, which are characterized by a fused ring system connected via an alkyl-aryl ether linkage (C-O-C) and a C-C cross-link. The enzyme DarE, using the radical S-adenosyl-l-methionine (rSAM), facilitates the formation of these bonds. Biosynthetic manipulation of the darobactin gene cluster, along with its expression in a surrogate host, has enabled access to diverse darobactin analogues with variable antibiotic activities. Recently, two independent research groups successfully achieved the total synthesis of darobactin, employing Larock heteroannulation to construct the bicyclic structure. This paper presents a comprehensive review of darobactins, encompassing their discovery through to the most recent advancements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology Bombay, Mumbai 400076, India.
ORCID-Profile: Venkateswarlu Yarlagadda
Förderung
- Wadhwani Research Centre for Bioengineering, Indian Institute of Technology Bombay
- University Grants Commission
- Science and Engineering Research Board
- Industrial Research and Consultancy Centre
- Ministry of Education, India
Zitieren
APA
Dutta, A., Sharma, P., Dass, D., & Yarlagadda, V. (2024). Exploring the Darobactin Class of Antibiotics: A Comprehensive Review from Discovery to Recent Advancements. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00412
Vancouver
Dutta A, Sharma P, Dass D, Yarlagadda V. Exploring the Darobactin Class of Antibiotics: A Comprehensive Review from Discovery to Recent Advancements. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00412
BibTeX
@article{Dutta2024,
author = {Dutta, Akash and Sharma, Peehu and Dass, Dharam and Yarlagadda, Venkateswarlu},
title = {Exploring the Darobactin Class of Antibiotics: A Comprehensive Review from Discovery to Recent Advancements},
journal = {ACS Infectious Diseases},
year = {2024},
doi = {10.1021/acsinfecdis.4c00412}
}
EUVIMED